COVID-19: MS; Children; Mental health Resources
For a full list of general info and research about COVID-19, please visit [UPDATED] COVID-19 Resources
Coping With Coronavirus: Managing Stress, Fear, and Anxiety
(Centers for Disease Control and Prevention on “Fear and anxiety about a new disease and what could happen can be overwhelming and cause strong emotions in adults and children. Public health actions, such as social distancing, can make people feel isolated and lonely and can increase stress and anxiety. However, these actions are necessary to reduce the spread of COVID-19. Coping with stress in a healthy way will make you, the people you care about, and your community stronger.”
Emotional & mental health and COVID-19
Mental health & COVID-19, World Health Organisation
#HealthyAtHome – Mental health, World Health Organisation
#HealthyAtHome – Physical activity, World Health Organisation
Policy Brief: COVID-19 and the Need for Action on Mental Health, World Health Organisation
Helping children cope with COVID-19
Children’s story book released to help children and young people cope with COVID-19, World Health Organisation
Talking with children about Coronavirus Disease 2019: Messages for parents, school staff, and others working with children, Centers for Disease Control and Prevention
Infographic: Helping children cope with stress during the 2019-nCov outbreak, World Health Organisation
Coronavirus Resources for Families | Mental and Emotional Health: Returning to School, Coping with Stress and Anxiety, Grief Tools, Cognitive Behavioral Therapy – Tools for Kids, Cincinnati Children’s
Multiple sclerosis and the novel coronavirus
(Listed chronologically, newest first)
COVID-19 and Multiple Sclerosis, WebMD (September 23rd, 2020)
An Italian programme for COVID-19 infection in multiple sclerosis, The Lancet Neurology (June 1st, 2020)
How Has COVID-19 Changed Multiple Sclerosis Care?, AJMC (April 25th, 2020)
Have You Tested Positive for Coronavirus with MS? Multiple Sclerosis News Today (March 20th, 2020)
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies, US National Library of Medicine, National Institutes of Health (February 1st, 2020)
COVID-19 and people with disabilities, Centers for Disease Control and Prevention
2018 Winner Best Blog Post with ‘3443 Needles’, Blog Awards Ireland, Ashville Media Group, Dublin, Ireland© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2023. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and irelandms.com with appropriate and specific direction to the original content.
